Search results
Horizon Discovery drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for ...
Broadly useful across many applications and in any cell line, siRNA offers a straightforward and widely cited technique for functional gene silencing. For over 20 years, Dharmacon reagents have remained the most trusted name in high quality siRNA design and synthesis.
Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health.
On the path from research to therapy – Inspired Cell Solutions | Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene...
Nov 2, 2020 · Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine ...
Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes ...
Horizon Discovery Group plc (LSE: HZD) ("Horizon") drives the application of gene editing and gene modulation to support scientists on the path from research to therapy.
